Xcout Intel
GlycoEra
GlycoEra AG is a biotechnology company focused on advancing glycan-mediated therapy through game-changing protein engineering. Headquartered in Wädenswil, Switzerland, the company also maintains an office in Newton, Massachusetts.
Subscribe to see GlycoEra’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
GlycoEra at a glance
GlycoEra is a biotechnology company headquartered in Switzerland. Xcout tracks 14 named people at GlycoEra, including Ganesh V. Kaundinya, PhD (President & CEO).
GlycoEra leadership
- Ganesh V. Kaundinya, PhDPresident & CEO
- Andrea MatthewsChief Business Officer
- Petra Duda, M.D., Ph.D.Chief Medical Officer
- Tanmoy C. Ganguly, PhDChief Scientific Officer
- Georges GemayelChairperson
- Colleen GrahamSVP, Head of Clinical Operations
8 more named people on record for GlycoEra, with roles, board committees and tenure — see the full roster →
GlycoEra competitors
A few of GlycoEra's closest competitors — see the full list of competitors and alternatives →
Nabla Bio is a biotechnology company headquartered in Cambridge, Massachusetts. It develops protein engineering platforms and technical solutions.
Mythic Therapeutics, Inc. is a biotechnology research company headquartered in Waltham, Massachusetts. The company is dedicated to developing a proprietary platform to enhance the effectiveness of antibody-drug conjugates and other antibody-based therapeutics.
GlycoMimetics, Inc. is a U.S. biotechnology company that develops glycomimetic drugs designed to modulate carbohydrate-mediated biological interactions. Its programs have focused on therapeutics for diseases including cancer and inflammatory disorders, serving patients through partnerships and clinical development rather than as a direct consumer business.
Maxion Therapeutics is a biotechnology company headquartered in Cambridge, England, utilizing proprietary KnotBody technology to discover and develop first-in-class protein therapeutics.
Expedition Medicines, Inc. is a biotechnology company founded in 2022 and headquartered in Cambridge, Massachusetts, focused on generatively designing novel drugs targeting specific proteins.
Alloy Therapeutics, Inc. is a biotechnology ecosystem company dedicated to democratizing access to antibodies, multispecifics, and genetic modalities, with offices in Waltham and Boston, Massachusetts.
Get GlycoEra's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on GlycoEra in Xcout Intel
- 14 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access